Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study.

Author: Wei BAI ¹ ; Mengtao LI ¹ ; Shuang ZHOU ¹ ; Liying PENG ¹ ; Jiuliang ZHAO ¹ ; Xinping TIAN ¹ ; Qian WANG ¹ ; Xiaomei LENG ¹ ; Shangzhu ZHANG ¹ ; Yanhong WANG ² ; Yan ZHAO ¹ ; Xiaofeng ZENG ¹
Author Information

1. Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.
2. Department of Epidemiology and Bio-statistics (YW), Institute of Basic Medical Science, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100053, China.
Publication Type:Journal Article
MeSH: Humans; Tacrolimus/therapeutic use*; Lupus Erythematosus, Systemic/drug therapy*; Immunosuppressive Agents/therapeutic use*; Treatment Outcome
From: Chinese Medical Journal 2022;135(18):2245-2247
CountryChina
Language:English